IDiyas

For the Inventor, By the Inventor

Fishers, IN, United States of America

Edward C R Smith

USPTO Granted Patents = 17


Average Co-Inventor Count = 6.6

ph-index = 5

Forward Citations = 80(Granted Patents)


Location History:

  • Indianapolis, IN (US) (2001)
  • Fishers, IN (US) (2001 - 2011)

Company Filing History:

goldMedal17 out of 4,442 
 
Eli Lilly and Company
 patents

Years Active: 2001-2011

Loading Chart...
Loading Chart...
17 patents (USPTO):
1. 7960419 - Substituted carboxamides (2011-06-14),
2. 7935722 - Tetrahydrocarbazole derivatives useful as androgen receptor modulators (2011-05-03),
3. 7135487 - Sulphonamide derivatives (2006-11-14),
4. 7087626 - Pyrrole derivatives as pharmaceutical agents (2006-08-08),
5. 6974831 - sPLA2 inhibitors (2005-12-13),
6. 6930123 - sPLA2 inhibitors (2005-08-16),
7. 6916840 - Spla2 inhibitors (2005-07-12),
8. 6797723 - Heterocycle substituted diphenyl leukotriene antagonists (2004-09-28),
9. 6730694 - sPLA2 inhibitors (2004-05-04),
10. 6693137 - Sulphonamide derivatives (2004-02-17),
11. 6639107 - Cyclopentyl sulfonamide derivatives (2003-10-28),
12. 6596716 - 2-propane-sulphonamide derivatives (2003-07-22),
13. 6552086 - Sulfonamide derivatives (2003-04-22),
14. 6500865 - Sulfonamide derivatives (2002-12-31),
15. 6303816 - Sulphonamide derivatives (2001-10-16),

Title: The Innovations of Edward C R Smith: A Visionary in Pharmaceutical Patents

Introduction

Edward C R Smith, based in Fishers, Indiana, is a distinguished inventor with an impressive portfolio of 17 patents. His contributions primarily focus on pharmaceutical innovations aimed at improving human health and wellbeing. With his wealth of knowledge and creativity, he continues to pave the way for advancements in the field.

Latest Patents

Among his notable achievements are his latest patents, which address critical issues in medicine. The first, titled "Substituted Carboxamides", pertains to a substituted carboxamide compound, or a pharmaceutically acceptable salt thereof, that plays a significant role in treating pain. This compound shows promise in alleviating discomfort, highlighting the necessity for effective pain management solutions.

Another significant patent is for "Tetrahydrocarbazole Derivatives Useful as Androgen Receptor Modulators". This invention provides a compound that can treat various physiological disorders such as frailty, osteoporosis, osteopenia, and sexual dysfunction. By offering an effective treatment option, this innovation addresses the health challenges faced by many individuals.

Career Highlights

Edward C R Smith is currently affiliated with Eli Lilly and Company, a leading pharmaceutical enterprise recognized for its commitment to healthcare innovations. His role within the company allows him to combine his inventive spirit with a collaborative environment, contributing to the advancement of pharmaceutical sciences.

Collaborations

Throughout his career, Smith has collaborated with notable coworkers, including Dennis Michael Zimmerman and Paul Leslie Ornstein. Together, they have cultivated a rich environment of idea exchange and innovation, significantly enhancing their work and leading to groundbreaking discoveries.

Conclusion

Edward C R Smith exemplifies the spirit of innovation within the pharmaceutical industry. His substantial contributions through his patents not only reflect his expertise but also his dedication to improving health outcomes for individuals. With continued collaborations and ingenuity, Smith’s future inventions are anticipated to make a considerable impact on medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…